about
Cancer Risk and Eicosanoid Production: Interaction between the Protective Effect of Long Chain Omega-3 Polyunsaturated Fatty Acid Intake and GenotypeUnraveling the microenvironmental influences on the normal mammary gland and breast cancerThe Role of Non-Steroidal Anti-Inflammatory Drugs in the Chemoprevention of Breast Cancer.PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis.Cancer inflammation and regulatory T cells.Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control studyCOX-2 inhibitor nimesulide analogs are aromatase suppressors in breast cancer cellsA COX-2 inhibitor nimesulide analog selectively induces apoptosis in Her2 overexpressing breast cancer cells via cytochrome c dependent mechanisms.Preventative therapies for healthy women at high risk of breast cancer.Inhibiting delta-6 desaturase activity suppresses tumor growth in mice.Effects of celecoxib and ly117018 combination on human breast cancer cells in vitro.Overexpression of cyclooxygenase-2 in malignant peripheral nerve sheath tumor and selective cyclooxygenase-2 inhibitor-induced apoptosis by activating caspases in human malignant peripheral nerve sheath tumor cells.Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal.Effect of liposomal celecoxib on proliferation of colon cancer cell and inhibition of DMBA-induced tumor in rat model.Phase ii trial of a metronomic schedule of docetaxel and capecitabine with concurrent celecoxib in patients with prior anthracycline exposure for metastatic breast cancer.Ethanol enhances arsenic-induced cyclooxygenase-2 expression via both NFAT and NF-κB signalings in colorectal cancer cellsc-Myc modulation: a key role in melanoma drug response.Association of EP2 receptor and SLC19A3 in regulating breast cancer metastasis.Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis.Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms.Gut bacteria and cancerSynthesis and biological evaluation of novel sulfonanilide compounds as antiproliferative agents for breast cancer.A cross-talk between NFAT and NF-κB pathways is crucial for nickel-induced COX-2 expression in Beas-2B cellsAMP kinase/cyclooxygenase-2 pathway regulates proliferation and apoptosis of cancer cells treated with quercetin.Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesisOutpatient Follow-up and Secondary Prevention for Melanoma PatientsPrevention of posterior capsular opacification through cyclooxygenase-2 inhibition.Initiation of aspirin therapy modulates angiogenic protein levels in women with breast cancer receiving tamoxifen therapy.Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma.The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies.COX2 overexpression is a prognostic marker for Stage III breast cancer.Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects.Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines.Current and future developments in screening for ovarian cancer.15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS.Apoptosis induction and tumor cell repopulation: the yin and yang of radiotherapyMolecular mechanisms of mouse skin tumor promotion.Design, Synthesis, and Evaluation of New Tripeptides as COX-2 Inhibitors.Specific role of RhoC in tumor invasion and metastasis.Novel augmentation by bufalin of protein kinase C-induced cyclooxygenase-2 and IL-8 production in human breast cancer cells.
P2860
Q26764884-B2C1CE11-EF0B-43CE-BA43-6D70F1C6E964Q28473677-3F637451-D73A-414B-98CE-1A409929CEC9Q33664316-E9464041-2E58-482C-B69D-CA644CD1206EQ33752909-3B2F28B2-F60F-4BE7-8B0E-D36232E4C190Q33796582-A2EFDA46-0FBC-41D0-89A3-DFBF92D2990EQ33889458-19F67760-3B6A-4B05-9FB5-0C87F2465205Q34197516-46F675B5-B12C-4F83-A6AA-7A38BBE7D594Q34197523-68177210-813F-4FB5-8FCA-952E51A4F805Q34393592-E3C5B9E9-FD7E-4D10-A2E2-BC13F495EFCDQ34462192-F2BECAC0-419E-452B-A047-319DE2412D57Q34908885-5FEC0FE2-FE90-47A6-BB92-3C3CE29F9100Q35091515-354BB83E-3C6F-4EC0-BB01-31E42256D17FQ35653603-C9A6F40D-4C72-4A3D-B8E5-3827B83576A6Q35673644-97CA85E2-A97A-4BB2-9CF3-FDD54F1100ABQ35872701-FF608F07-5CD9-4BF0-ACE4-8B998140F0E0Q36103814-C91C9CE4-C51B-4CC2-8E72-F52712D6B4ECQ36213103-D503FAB1-85B0-4528-A921-342EAEED0CCDQ36420170-1E7BA8D4-383D-4636-84F7-DA5663E27ACFQ36545096-17C8C4A5-AF48-438A-A020-B27BC403AECBQ36959011-657807D9-C8AE-4906-946D-B69BBE42178BQ37082877-8DC72472-5E29-4310-9006-CC136A1D3630Q37104290-698F6B46-337C-48B4-AB6C-56B63770AE83Q37137516-D31AFC41-51F5-4EC7-9437-E682E7F60556Q37184785-37D74B13-BACB-418A-8DF5-576E2727C578Q37208786-8EBD9E64-EC57-4B4C-809A-59C69BEB61DDQ37328408-85BC0BF3-508E-43C0-B91A-6ED634E46F67Q37395621-393734F2-8006-4E66-92C5-ADF7C22A3197Q37700562-11A7CA57-E27A-4049-8C1D-10D556822346Q38097532-5B0DCA3C-CBB4-47B5-8978-930404D2B684Q38183889-2A19B9E5-1040-4D83-8605-96925E4AD262Q38474547-A0517A76-433F-4A3F-BBC3-6C8DCA067FAAQ38753349-83A7F344-A4D7-4308-A38D-ED244365B5F5Q39622594-1A3A1283-098B-448E-B299-8538AFC74881Q39902791-80885242-A3F2-40BC-AABA-C87603BFE81CQ40025534-0C72960D-F811-4059-B3E8-3B65769100C2Q40609896-43F53975-9AA3-4A8C-9D18-E4EAD86C9148Q42589687-39D04D6C-5093-47EE-90FF-682A513ED502Q43226712-83A1968D-3B2A-4011-9488-0AB5F4F1D751Q47103516-2D2B0AE0-2FBC-438B-8F55-B09AEF8452CDQ47259640-D2D57007-8DE8-43C2-B9CE-17E30837F09F
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
COX inhibitors and breast cancer
@ast
COX inhibitors and breast cancer
@en
COX inhibitors and breast cancer
@nl
type
label
COX inhibitors and breast cancer
@ast
COX inhibitors and breast cancer
@en
COX inhibitors and breast cancer
@nl
prefLabel
COX inhibitors and breast cancer
@ast
COX inhibitors and breast cancer
@en
COX inhibitors and breast cancer
@nl
P2093
P2860
P921
P356
P1476
COX inhibitors and breast cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602942
P407
P577
2006-02-13T00:00:00Z
P5875
P6179
1044055154